Endothelin receptor heterogeneity; structure activity, autoradiographic and functional studies

Area of Science:

• Pharmacology
• Neuroscience
• Cardiovascular Research

Background:

• Endothelin-1 (ET-1) and endothelin-3 (ET-3) are vasoactive peptides with diverse physiological roles.
• Endothelin receptors mediate various cellular responses, but their heterogeneity and distribution are not fully elucidated.
• Understanding endothelin receptor subtypes is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the binding characteristics and functional activity of ET-1, ET-3, and a synthetic ET-1 analogue ([Ala1,3,11,15]ET-1) in rat aorta and cerebellum.
• To determine the cellular localization of endothelin-1 receptors in these tissues using autoradiography.

Main Methods:

• Radioligand binding assays using [125I]endothelin-1 to assess inhibition constants (Ki) for ET-1, ET-3, and [Ala1,3,11,15]ET-1.
• Functional studies in rat aorta to evaluate the agonist/antagonist activity of ET-3 and [Ala1,3,11,15]ET-1.
• Autoradiography to visualize endothelin receptor distribution in aorta and cerebellum.

Main Results:

• Inhibition curves differed between aorta and cerebellum, suggesting receptor heterogeneity.
• ET-3 binding in the aorta was biphasic, indicating two distinct binding sites.
• [Ala1,3,11,15]ET-1 was inactive in the aorta but showed similar binding to ET-1 and ET-3 in the cerebellum.
• Endothelin-1 receptors were localized to vasculature (including endothelium, smooth muscle, nerves) in the aorta and neuronal elements in the cerebellum's granular cell layer.

Conclusions:

• Findings support the existence of distinct endothelin receptor subtypes with differential distribution and function in the vasculature and central nervous system.
• The specific cellular localization of endothelin-3 binding sites and the functional role of high-affinity ET-3 binding require further investigation.